Talk:Lanreotide

Improvement

To do:

• Find more info for Drugbox
• Avoid repetition of name—lanreotide, lanreotide, lanreotide...
• Find more refs and better refs
• Add more on the use of radiolabeled lanreotide?
• Add more on efficacy and comparison to octreotide.
• Interesting refs:
  • Freda P, Katznelson L, van der Lely A, Reyes C, Zhao S, Rabinowitz D (2005). "Long-acting somatostatin analog therapy of acromegaly: a meta-analysis". J Clin Endocrinol Metab. 90 (8): 4465–73. PMID 15886238.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  • Kaltsas G, Papadogias D, Makras P, Grossman A (2005). "Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues". Endocr Relat Cancer. 12 (4): 683–99. PMID 16322317.{{cite journal}}: CS1 maint: multiple names: authors list (link) Free full text

Fvasconcellos 02:55, 3 March 2007 (UTC)

Oral Lanreotide

Do you think that one day there will be an oral form of Lanreotide or octreotide? —Preceding unsigned comment added by Interestedperson (talk • contribs)

Well, there has been some development of orally active somatostatin analogues,^[1][2][3] although not recently AFAIK. Very high oral doses of octreotide do produce some effect, comparable to a low parenteral dose (there's a reference for that somewhere). Perhaps somatostatin analogues with appropriate structural modifications will reach the market someday... Fvasconcellos (t·c) 19:19, 17 July 2007 (UTC)

...peptide?

question: what kind of peptide is lanreotide? is it an octapeptide like octreotide? Nomoremissniceguy (talk) 10:01, 21 January 2010 (UTC)

from the diagram it looks like 9 amino acids. - Rod57 (talk) 09:24, 6 July 2015 (UTC)

Needs info on clinical trial results

and the first half of the Indications section needs slight rewording to reflect the 2014 approval. - Rod57 (talk) 09:28, 6 July 2015 (UTC)